Clinical Trials Browser

OTHER × Sarcoma × Bevacizumab × Clear all

NCT01746238 2026-04-17

Bevacizumab/Doxorubicin/Radiation for Sarcoma

Phase 1 Active not recruiting

Sarcoma

NCT05075993 2025-12-26

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Phase 1 Active not recruiting

DermatologicGastrointestinalGynecologicSarcoma

Uveal Melanoma, Carcinoma, Hepatocellular, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms

NCT01552434 2025-10-14

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Phase 1 Active not recruiting

BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT01492673 2019-10-29

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Phase 2 Completed

9 enrolled 9 charts

Neuroblastoma, Sarcoma, Sarcoma, Ewing

NCT01661283 2019-03-06

SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors

Phase 2 Completed

25 enrolled 15 charts

Sarcoma, Neurofibrosarcoma

NCT01106872 2018-08-10

Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas

Phase 1 Completed

Sarcoma

NCT00288015 2018-06-25

Bevacizumab in Treating Patients With Angiosarcoma

Phase 2 Completed

32 enrolled 12 charts

Hemangiosarcoma, Sarcoma

NCT01055028 2018-03-26

Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma

Phase 2 Terminated

18 enrolled 13 charts

Hemangiosarcoma, Sarcoma

NCT00356031 2017-05-19

Bevacizumab and Radiation Therapy for Sarcomas

Phase 2 Completed

20 enrolled 16 charts

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Histiocytoma, Benign Fibrous

NCT00887809 2016-01-25

Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

Phase 2 Completed

47 enrolled 7 charts

Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Histiocytoma

NCT00276055 2015-06-19

Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma

Phase 1 Completed

Sarcoma

NCT00755261 2015-05-08

Phase II Study of Doxorubicin and Avastin® in Sarcoma.

Phase 2 Terminated

4 enrolled 4 charts

Sarcoma